window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

patient care

  • Central Nervous System,Clinical Development,Market Access & Commercialization,Patient Centricity,Pharmaceuticals and therapeutics

    Bristol Myers Squibb to launch Cobenfy in the UK at US list price for adults with schizophrenia

    Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

    September 23, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Development,Clinical Trials,Patient Centricity

    New study shows Aurase wound gel enables painless debridement of chronic wounds

    Peer-reviewed paper highlights pain-free enzymatic approach for venous leg ulcers [...]

    July 17, 2025
  • Partnerships & Funding,Technology and platforms

    Carta Healthcare raises $18.25M to expand AI-driven clinical data abstraction platform

    Carta Healthcare has secured $18.25 million in Series B1 financing [...]

    May 8, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Development, Oncology, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top